<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30201" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>TIMI Grade Flow</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sarkar</surname>
            <given-names>Abdullah</given-names>
          </name>
          <aff>University of Miami</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Grigg</surname>
            <given-names>William S.</given-names>
          </name>
          <aff>Parkview Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>John J.</given-names>
          </name>
          <aff>University of Miami</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abdullah Sarkar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>William Grigg declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Lee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30201.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Acute myocardial infarction (MI) is the leading cause of death worldwide. It has been&#x000a0;widely&#x000a0;accepted that it is due to the insufficient blood supply to the cardiac tissue. In an attempt to intervene, physicians&#x000a0;in the 1970s&#x000a0;studied ligation of canine coronary arteries and documented prevention of necrosis with&#x000a0;ligation release under appropriate time limits. Initial&#x000a0;therapeutic reperfusion was established using&#x000a0;intravenous and intracoronary thrombolytic agents, and several studies were conducted on them.<xref ref-type="bibr" rid="article-30201.r1">[1]</xref><xref ref-type="bibr" rid="article-30201.r2">[2]</xref><xref ref-type="bibr" rid="article-30201.r3">[3]</xref><xref ref-type="bibr" rid="article-30201.r4">[4]</xref></p>
      </sec>
      <sec id="article-30201.s2" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>In&#x000a0;1983, the TIMI (Thrombolysis in Myocardial Infarction) study group (Brigham and Women's Hospital, Boston, Massachusetts) chose to conduct a randomized, double-blind, multicenter study to assess the efficacy of intravenous (IV) streptokinase. Phase 1 studied IV streptokinase and IV tPA (tissue plasminogen activator) and assessed&#x000a0;"recanalization of the totally occluded artery 90 minutes after the start of drug infusion." For this study, the <italic toggle="yes">TIMI Coronary Grade Flow </italic>was&#x000a0;established to ensure a uniform and consistent method of recording&#x000a0;epicardial perfusion on coronary arteriography. TIMI grade flow 0 represented&#x000a0;total occlusion, and TIMI grade flow 3 represented&#x000a0;normal epicardial perfusion. Images were evaluated at the clinical site and later at a central radiographic lab to further ensure consistency.&#x000a0;In 1985, due to statistically significant differences in recanalization rates with tPA over streptokinase, phase 1 of the study was stopped.<xref ref-type="bibr" rid="article-30201.r5">[5]</xref><xref ref-type="bibr" rid="article-30201.r6">[6]</xref><xref ref-type="bibr" rid="article-30201.r7">[7]</xref></p>
        <p>
<bold>Definitions of Perfusion </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Grade 0</bold> (no perfusion): There is no antegrade flow beyond the point of occlusion.</p>
          </list-item>
          <list-item>
            <p><bold>Grade 1</bold> (penetration without perfusion): The contrast material passes beyond the area of obstruction but &#x0201c;hangs up&#x0201d; and fails to opacify the entire coronary bed distal to the obstruction for the duration of the cine-angiographic filming sequence.</p>
          </list-item>
          <list-item>
            <p><bold>Grade 2</bold> (partial perfusion): The contrast material passes across the obstruction and opacifies the coronary bed distal to the obstruction. The rate of entry of the contrast material into the vessel distal to the obstruction or the rate of clearance from the distal bed&#x000a0;is perceptibly slower than its entry into or clearance from comparable areas not perfused by the previously occluded vessel&#x02014;e.g., the opposite coronary artery or the coronary bed proximal to the obstruction.</p>
          </list-item>
          <list-item>
            <p><bold>Grade 3</bold> (complete perfusion): Antegrade flow into the bed distal to the obstruction occurs as promptly as antegrade flow into the bed proximal to the obstruction, and clearance of contrast material from the involved bed is as rapid as clearance from an uninvolved bed in the same vessel or the opposite artery.</p>
          </list-item>
        </list>
        <p>Limitations of the TIMI grade flow include observer variability, and it only provides categorical values instead of continuous ones. However, the TIMI study group also developed additional scoring systems. TIMI frame count (TFC) measures the number of cine-angiographic frames to reach standardized distal landmarks, thus providing a quantitative assessment of epicardial flow. It was established to enhance the reproducibility of the angiographic assessment.</p>
        <p>As TIMI grade flow and TFC assess epicardial flow, TIMI myocardial perfusion (TMP) grade was developed to assess microvascular perfusion. Using myocardial contrast echocardiography, a visual assessment is made of contrast density in the infarcted myocardium after reperfusion therapy. It is scored 0 to 3, with &#x0201c;0 representing no apparent tissue-level perfusion and TMP 3 indicating normal perfusion.&#x0201d; It has been shown that despite having a TIMI grade flow of 3, some patients have no reflow in the myocardium (TMP 0). TMP has also been shown to be an independent predictor of mortality.<xref ref-type="bibr" rid="article-30201.r8">[8]</xref><xref ref-type="bibr" rid="article-30201.r6">[6]</xref></p>
        <p>
<bold>Definitions of TMP Grades</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>TMP Grade 0:</bold> Failure of dye to enter the microvasculature. Either minimal or no ground-glass appearance (&#x0201c;blush&#x0201d;) or opacification of the myocardium in the distribution of the culprit artery, indicating lack of tissue-level perfusion.</p>
          </list-item>
          <list-item>
            <p><bold>TMP Grade 1:</bold> Dye slowly enters but fails to exit the microvasculature. There is the ground-glass appearance (&#x0201c;blush&#x0201d;) or opacification of the myocardium in the distribution of the culprit lesion that fails to clear from the microvasculature, and dye staining is present on the next injection (approximately 30 seconds between injections).</p>
          </list-item>
          <list-item>
            <p><bold>TMP Grade 2:</bold> Delayed entry and exit of dye from the microvasculature. There is a ground-glass appearance or opacification of the myocardium in the distribution of the culprit lesion that is strongly persistent at the end of the washout phase (i.e., the dye is strongly persistent after three cardiac cycles of the washout phase and either does not or only minimally diminishes in intensity during washout).</p>
          </list-item>
          <list-item>
            <p><bold>TMP Grade 3:</bold> Normal entry and exit of dye from the microvasculature. There is the ground-glass appearance (&#x0201c;blush&#x0201d;) or opacification of the myocardium in the distribution of the culprit lesion that clears normally and is either gone or only mildly/moderately persistent at the completion of the washout phase (i.e., dye is gone or is mildly/moderately persistent after 3 cardiac cycles of the washout phase and noticeably diminishes in intensity during the washout phase), similar to that in an uninvolved artery. The blush that is of only mild intensity throughout the washout phase but fades minimally is also classified as grade 3.</p>
          </list-item>
        </list>
        <p>The <italic toggle="yes">TIMI Coronary Grade Flow</italic> is an effective and well-studied grading system of coronary reperfusion on an angiogram. Achieving earlier TIMI grade 3 flow has been correlated with improved survival in both reperfusions with thrombolysis or primary percutaneous coronary intervention (PCI). Additionally, combining TIMI grade flow and TMP can stratify patients at very low risk and high risk for mortality post-STEMI. Proven a useful tool in patients with acute MI, the TIMI grade flow is used routinely.<xref ref-type="bibr" rid="article-30201.r9">[9]</xref><xref ref-type="bibr" rid="article-30201.r10">[10]</xref></p>
      </sec>
      <sec id="article-30201.s3" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Since the initial TIMI 1 study, the TIMI flow grading system has been used globally to measure epicardial flow and is considered the &#x0201c;gold standard&#x0201d; model compared to other modalities. It has been studied to show the predictability of clinical outcomes. The global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO) studied TIMI grade flows and 30-day mortality. The original investigators analyzed data from the GUSTO trial and noted &#x0201c;a lack of patency at 90 minutes (TIMI grade 0 or 1) was associated with mortality of 8.9 percent, and patency (TIMI grade 2 or 3) with mortality of 5.7 percent (P = 0.04). The mortality rate among patients with TIMI grade 2 flow was 7.4 percent, and the rate among those with TIMI grade 3 flow was 4.4 percent (P = 0.08). The difference between the mortality rate associated with grade 3 and the rate associated with grade 0 or 1 was significant (P = 0.009).&#x0201d;</p>
        <p>Additionally, patients with TIMI 3 before angioplasty are less likely to develop left ventricular complications and have improved survival. Other examples of clinical significance include a demonstration of increased mortality risk in a patient with low TIMI grade flow (0-2) post-PCI for STEMI among patients with cardiogenic shock, compared to normal post-PCI TIMI grade flow.</p>
      </sec>
      <sec id="article-30201.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30201&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30201">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30201/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30201">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30201.s5">
        <title>References</title>
        <ref id="article-30201.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>At&#x00131;c&#x00131;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Erturk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baycan</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Fidan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Demirel</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Asoglu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Demir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ozturk</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Elitok</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Okuyan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Multilayer longitudinal strain can help predict the development of no-reflow in patients with acute coronary syndrome without ST elevation.</article-title>
            <source>Int J Cardiovasc Imaging</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>10</issue>
            <fpage>1811</fpage>
            <page-range>1811-1821</page-range>
            <pub-id pub-id-type="pmid">31093895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bauer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zeymer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Diallo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vicaut</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bolognese</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cequier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Montalescot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hamm</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Van't Hof</surname>
                <given-names>AW</given-names>
              </name>
              <collab>ATLANTIC Investigators</collab>
            </person-group>
            <article-title>Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2020</year>
            <month>Feb</month>
            <day>15</day>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>494</fpage>
            <page-range>494-500</page-range>
            <pub-id pub-id-type="pmid">31067010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somuncu</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Akgun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cak&#x00131;r</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Akgul</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Serbest</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Karakurt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Can</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Demir</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.</article-title>
            <source>J Atheroscler Thromb</source>
            <year>2019</year>
            <month>Nov</month>
            <day>01</day>
            <volume>26</volume>
            <issue>11</issue>
            <fpage>970</fpage>
            <page-range>970-978</page-range>
            <pub-id pub-id-type="pmid">30996145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kewcharoen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trongtorsak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kittipibul</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Prasitlumkum</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kanitsoraphan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Putthapiban</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mekraksakit</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pattison</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Rattanawong</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Fragmented QRS predicts reperfusion failure and in-hospital mortality in ST-Elevation myocardial infarction: a systematic review and meta-analysis.</article-title>
            <source>Acta Cardiol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>298</fpage>
            <page-range>298-311</page-range>
            <pub-id pub-id-type="pmid">31021694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vyshlov</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Krylov</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Syrkina</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Alexeeva</surname>
                <given-names>YV</given-names>
              </name>
              <name>
                <surname>Demyanov</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Baev</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Markov</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Ryabov</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>[Not Available].</article-title>
            <source>Kardiologiia</source>
            <year>2019</year>
            <month>Mar</month>
            <day>07</day>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>5</fpage>
            <page-range>5-9</page-range>
            <pub-id pub-id-type="pmid">30853015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Imaeda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ryuzaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yokokura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamazaki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tabei</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kodaira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Numasawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Novel Insights of Jailed Balloon and Jailed Corsair Technique for Percutaneous Coronary Intervention of Bifurcation Lesions.</article-title>
            <source>Cardiovasc Revasc Med</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>12</issue>
            <fpage>1065</fpage>
            <page-range>1065-1072</page-range>
            <pub-id pub-id-type="pmid">30819656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zachura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilczek</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Janion</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x00105;sior</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gierlotka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sadowski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcomes in men and women with ST-segment elevation myocardial infarction and incomplete reperfusion after a primary percutaneous coronary intervention: a 2-year follow-up.</article-title>
            <source>Coron Artery Dis</source>
            <year>2019</year>
            <month>May</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-176</page-range>
            <pub-id pub-id-type="pmid">30973830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Briguori</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Visconti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Golino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Focaccio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Signoriello</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Sirolimus-eluting BiOSS LIM dedicated bifurcation stent in the treatment of unprotected distal left main stenosis.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2019</year>
            <month>Sep</month>
            <day>01</day>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>323</fpage>
            <page-range>323-331</page-range>
            <pub-id pub-id-type="pmid">30773807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Delayed vs. immediate stenting in STEMI with a&#x000a0;high thrombus burden : A&#x000a0;systematic review and meta-analysis.</article-title>
            <source>Herz</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>44</volume>
            <issue>8</issue>
            <fpage>726</fpage>
            <page-range>726-734</page-range>
            <pub-id pub-id-type="pmid">29651617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30201.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bulluck</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hammond-Haley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weinmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martinez-Macias</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hausenloy</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Myocardial Infarct Size by CMR in Clinical&#x000a0;Cardioprotection Studies: Insights From Randomized Controlled Trials.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>230</fpage>
            <page-range>230-240</page-range>
            <pub-id pub-id-type="pmid">28279370</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
